Doximity, Inc.DOCSEarnings & Financial Report
NYSE · online service provider
Doximity is an online networking service for medical professionals. Launched in 2010, the platform offers its members curated medical news, telehealth tools, and case collaboration.
NextMay 20, 2026
DOCS Q3 2026 Key Financial Metrics
Revenue
$185.1M
Gross Profit
$166.4M
Operating Profit
$71.9M
Net Profit
$61.6M
Gross Margin
89.9%
Operating Margin
38.9%
Net Margin
33.3%
YoY Growth
9.8%
EPS
$0.31
Financial Flow
Doximity, Inc. Q3 2026 Financial Summary
Doximity, Inc. reported revenue of $185.1M for Q3 2026, with a net profit of $61.6M (33.3% margin). Cost of goods sold was $18.7M, operating expenses totaled $94.5M.
Key Financial Metrics
| Total Revenue | $185.1M |
|---|---|
| Net Profit | $61.6M |
| Gross Margin | 89.9% |
| Operating Margin | 38.9% |
| Report Period | Q3 2026 |
Doximity, Inc. Annual Revenue by Year
Doximity, Inc. annual revenue history includes year-by-year totals (for example, 2025 revenue was $570.4M).
| Year | Annual Revenue |
|---|---|
| 2025 | $570.4M |
| 2024 | $475.4M |
| 2023 | $419.1M |
| 2022 | $343.5M |
Income Statement
| Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | Q3 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $118.1M | $126.7M | $136.8M | $168.6M | $138.3M | $145.9M | $168.5M | $185.1M |
| YoY Growth | 6.4% | 16.8% | 20.4% | 24.6% | 17.1% | 15.2% | 23.2% | 9.8% |
Balance Sheet
| Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | Q3 2026 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $1.08B | $1.07B | $1.12B | $1.17B | $1.26B | $1.20B | $1.26B | $1.16B |
| Liabilities | $178.0M | $159.9M | $157.3M | $141.0M | $181.7M | $178.9M | $161.6M | $177.7M |
| Equity | $901.4M | $913.6M | $961.2M | $1.03B | $1.08B | $1.03B | $1.10B | $979.3M |
Cash Flow
| Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | Q3 2026 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $63.9M | $41.2M | $68.3M | $65.2M | $98.5M | $62.1M | $93.9M | $60.9M |